Skip to content

Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis

Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis: a randomised controlled multicentre observer-blinded trial (Dutch Acute Pancreatitis Study Group)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN07091918
Enrollment
20
Registered
2007-03-28
Start date
2007-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute necrotising pancreatitis Digestive System Acute pancreatitis

Interventions

Endoscopic transgastric necrosectomy or necrosectomy by laparotomy, followed by continuous post-operative lavage

Sponsors

St Antonius Hospital Nieuwegein (Netherlands)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age equal to or above 18 years 2. Pancreatic necrosis or peripancreatic necrosis detected on contrast-enhanced computed tomography (CECT) 3. Patients in whom a decision for surgical intervention has been made because of (suspected) infected (peri-)pancreatic necrosis 4. Safe access route for endoscopic transgastric necrosectomy 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Participation in another intervention trial that would interfere with the intervention and outcome of this study 2. Previous surgical necrosectomy for (suspected) infected pancreatic necrosis, including procedures performed in referring hospitals. Previous percutaneous or transgastric drainage is allowed 3. Previous exploratory laparotomy for acute abdomen and diagnosis of pancreatitis during laparotomy 4. Acute flare-up of chronic pancreatitis 5. Bleeding, abdominal compartment syndrome or perforation of a visceral organ as indication for intervention 6. Post-abdominal surgery necrotising pancreatitis

Design outcomes

Primary

MeasureTime frame
Pro-inflammatory response as measured by the maximum increase in level of serum cytokine Interleukin six (IL-6) in the period between start of the first necrosectomy and five hours thereafter

Secondary

MeasureTime frame
1. Complications (bleeding, perforation, pancreatic fistula, pancreatic pseudocyst requiring intervention, pancreatic abscess requiring intervention, biliary strictures, incisional hernia requiring re-intervention and pancreatic insufficiency) 2. Mortality 3. Total number of interventions 4. Total hospital stay 5. Total intensive care stay

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 26, 2026